Capital Advisors Ltd
VRTX icon

Capital Advisors Ltd’s Vertex Pharmaceuticals VRTX Stock Holding History

Capital Advisors Ltd’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$59K Buy
113
+14
+14% +$7.17K 0.01% 482
2026
Q2 		$49K Buy
99
+30
+43% +$13.3K ﹤0.01% 516
2026
Q1 		$31K Sell
69
-8
-10% -$3.73K ﹤0.01% 596
2025
Q4 		$35K Buy
77
+27
+54% +$11.6K ﹤0.01% 563
2025
Q3 		$20K Buy
50
+2
+4% +$836 ﹤0.01% 650
2025
Q2 		$21K Hold
48
– – ﹤0.01% 619
2025
Q1 		$23K Buy
48
+17
+55% +$7.92K ﹤0.01% 596
2024
Q4 		$12K Sell
31
-3
-9% -$1.39K ﹤0.01% 749
2024
Q3 		$16K Hold
34
– – ﹤0.01% 662
2024
Q2 		$16K Sell
34
-2
-6% -$868 ﹤0.01% 639
2024
Q1 		$15K Buy
36
+6
+20% +$2.54K ﹤0.01% 645
2023
Q4 		$12K Hold
30
– – ﹤0.01% 670
2023
Q3 		$10K Sell
30
-1
-3% -$350 ﹤0.01% 692
2023
Q2 		$11K Hold
31
– – ﹤0.01% 688
2023
Q1 		$10K Buy
31
+9
+41% +$2.7K ﹤0.01% 567
2022
Q4 		$6K Hold
22
– – ﹤0.01% 639
2022
Q3 		$6K Hold
22
– – ﹤0.01% 613
2022
Q2 		$6K Buy
22
+13
+144% +$3.48K ﹤0.01% 561
2022
Q1 		$2K Buy
9
+6
+200% +$1.42K ﹤0.01% 657
2021
Q4 		$1K Buy
+3
New +$583 ﹤0.01% 761

Other funds holding VRTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Capital Advisors Ltd's VRTX Position: Q3 2026 in Review

Capital Advisors Ltd increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q3 2026, buying an estimated $7.17K and bringing the position to 113 shares worth $59K. The position accounts for 0.01% of the portfolio, ranked #482.

Capital Advisors Ltd first reported a position in VRTX in Q4 2021 and has held it in 20 quarters since. 992 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Capital Advisors Ltd held 113 shares of Vertex Pharmaceuticals worth $59K as of Q3 2026.
  • Capital Advisors Ltd bought 14 Vertex Pharmaceuticals shares in Q3 2026, an estimated $7.17K.
  • Vertex Pharmaceuticals made up 0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #482 holding.
  • Capital Advisors Ltd first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
  • 992 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.